Acarten 50 Tablet contains Acarbose 50mg, an oral antidiabetic agent indicated for the management of type 2 diabetes. By inhibiting intestinal alpha-glucosidase enzymes, it slows carbohydrate absorption and helps control post-meal blood glucose levels.
This tablet falls under the diabetes care segment, providing an effective adjunct therapy for patients along with diet and lifestyle modifications. Its higher-dose formulation allows flexibility for physicians to optimize therapy based on patient needs.
Acarten 50 Tablet is commonly prescribed by endocrinologists, general physicians, hospitals, and clinics, making it a high-demand product for PCD pharma distribution. Its clinical efficacy and safety profile promote better patient adherence and repeat prescriptions.
For PCD pharma franchise and B2B partners, Acarten 50 Tablet represents a profitable and in-demand opportunity. Its relevance in diabetes care portfolios, hospital demand, and widespread patient population ensures sustainable business growth, making it ideal for domestic distribution, export, and third-party manufacturing.